ASCO: Eribulin results ‘a giant step for sarcoma’

CHICAGO – For the first time ever, a new drug has shown a survival advantage – albeit a small one – in metastatic soft tissue sarcomas, diseases that are almost without exception unresponsive to...

Field of Interest: Oncology
Type: News Item

VIDEO: Nivolumab puts brakes on advanced liver cancer

CHICAGO – Immune checkpoint inhibition with nivolumab every 2 weeks provides a better response than does standard treatment for advanced liver cancer, phase I/II results suggest. The overall...

Field of Interest: Oncology
Type: News Item

Thyroid surgery on the rise

There was a steady rise in the number of endocrine procedures being performed in the United States over the past decade, according to a new publication from the Endocrine Society. Thyroid disease...

Field of Interest: Pulmonology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.